Literature DB >> 19692058

Recruitment of bone marrow derived cells to the bladder after bladder outlet obstruction.

Stacy T Tanaka1, Magaly Martinez-Ferrer, John H Makari, Marcia L Wills, John C Thomas, Mark C Adams, John W Brock, John C Pope, Neil A Bhowmick.   

Abstract

PURPOSE: Bladder fibrosis is an undesired end point of partial bladder outlet obstruction. In fibrotic disease of the lung, kidney, skin and heart chemokines recruit bone marrow derived cells to injured tissue. Blockade of chemokines like CCL2 results in decreased fibrosis in other organs. To our knowledge we present the first report of bone marrow derived cell recruitment to the bladder in a murine bladder outlet obstruction model.
MATERIALS AND METHODS: We lethally irradiated WT female mice and reconstituted their bone marrow using fetal liver cells from transgenic mice ubiquitously expressing green fluorescent protein. Periurethral collagen injection was used for bladder outlet obstruction. Obstruction was assessed by urodynamics, and bladder and kidney histological changes. Bladders were harvested 1 to 12 weeks after bladder outlet obstruction and compared to those in nonobstructed controls. The chemokine CCL2 was compared between obstructed and nonobstructed mice with reverse transcriptase-polymerase chain reaction. Green fluorescent protein expressing bone marrow derived cells were identified with immunohistochemistry and fluorescence activated cell sorting.
RESULTS: Bladders showed histological and urodynamic changes consistent with obstruction. CCL2 induction increased after obstruction compared to that in controls. After obstruction bone marrow derived cells were present in the urothelial and stromal layers. Activated epidermal growth factor receptor was found in cells associated with bone marrow derived cells.
CONCLUSIONS: Bone marrow derived cells are recruited to the bladder by bladder outlet obstruction and are present in the urothelial and stromal layers. Stromal bone marrow derived cells may have a role in hypertrophy and fibrosis. Further study of the recruitment and function of bone marrow derived cells in the bladder may provide potential targets for antifibrotic therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19692058     DOI: 10.1016/j.juro.2009.02.081

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Mesenchymal stem cells and the embryonic reawakening theory of BPH.

Authors:  W Nathaniel Brennen; John T Isaacs
Journal:  Nat Rev Urol       Date:  2018-11       Impact factor: 14.432

Review 2.  Bone marrow mesenchymal stem cell therapy for voiding dysfunction.

Authors:  Alice Yu; Lysanne Campeau
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

3.  Stem cell therapy for the bladder--where do we stand?

Authors:  Ching-Shwun Lin
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

4.  Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall.

Authors:  Stephanie L Osborn; Michelle So; Shannon Hambro; Jan A Nolta; Eric A Kurzrock
Journal:  Tissue Eng Part A       Date:  2015-04-22       Impact factor: 3.845

5.  Studies of ultrastructure, gene expression, and marker analysis reveal that mouse bladder PDGFRA+ interstitial cells are fibroblasts.

Authors:  Dennis R Clayton; Wily G Ruiz; Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-14

6.  Bone marrow-derived mesenchymal stem cells: current and future applications in the urinary bladder.

Authors:  Beth A Drzewiecki; John C Thomas; Stacy T Tanaka
Journal:  Stem Cells Int       Date:  2011-01-03       Impact factor: 5.443

7.  Human amniotic fluid stem cells can alleviate detrusor dysfunction caused by bladder outlet obstruction in rats.

Authors:  Ching-Chung Liang; Wen-Chu Huang; Steven W Shaw; Yung-Hsin Huang; Tsong-Hai Lee
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

Review 8.  Stem cell therapy in bladder dysfunction: where are we? And where do we have to go?

Authors:  Jae Heon Kim; Sang-Rae Lee; Yun Seob Song; Hong Jun Lee
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411

9.  The Murine Bladder Supports a Population of Stromal Sca-1+/CD34+/lin- Mesenchymal Stem Cells.

Authors:  Meredith A Lilly; Natalie A Kulkulka; Paula R Firmiss; Michael J Ross; Andrew S Flum; Grace B Delos Santos; Diana K Bowen; Robert W Dettman; Edward M Gong
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

Review 10.  Treatment of bladder dysfunction using stem cell or tissue engineering technique.

Authors:  Jae Heon Kim; Hong Jun Lee; Yun Seob Song
Journal:  Korean J Urol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.